Ever Source Wealth Advisors, LLC Bio N Tech Se Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 57 shares of BNTX stock, worth $5,989. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57
Previous 112
49.11%
Holding current value
$5,989
Previous $10,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BNTX
# of Institutions
320Shares Held
40.9MCall Options Held
1.37MPut Options Held
1.52M-
Baillie Gifford & CO8.04MShares$845 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$444 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$420 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$378 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$199 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...